Related Experiment Video
Updated: Apr 8, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
The Immunology of Glaucoma
T H Khanh Vu1, Martine J Jager, Dong Feng Chen
1From the *Schepens Eye Research Institute, Massachusetts Eye and Ear, and Department of Ophthalmology, Harvard Medical School, Boston, MA; †Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands; and ‡Veteran Affairs Boston Healthcare System, Boston, MA.
The immune system, including specific antibodies and T cells, may contribute to glaucoma. Further research is vital to understand these autoimmune responses and develop new treatments for neurodegenerative damage.
Area of Science:
- Immunology
- Ophthalmology
- Neuroscience
Background:
- Glaucoma's pathogenesis is not fully understood, particularly the role of the immune system.
- Evidence suggests immune system involvement in glaucomatous optic neuropathy.
- Current understanding of immunological mechanisms in glaucoma is limited.
Purpose of the Study:
- To review evidence for autoimmune responses in glaucoma pathogenesis.
- To explore the dual role of immune responses (detrimental vs. protective).
- To highlight the need for further research into immune system roles and potential treatments.
Main Methods:
- Review of existing literature on immune system involvement in glaucoma.
- Analysis of studies detecting autoantibodies, T cells, cytokines, and stress proteins in glaucoma patients.
- Examination of the balance between immune-positive and negative regulators.
Main Results:
- Presence of specific antibodies and T cells in glaucoma patients suggests immune system involvement.
- Autoimmune responses, including autoantibodies and T cells, are detected in glaucoma.
- Cytokines and stress proteins are expressed in glaucoma patients, indicating immune activity.
Conclusions:
- The immune system likely plays a role in the initiation and/or progression of glaucomatous optic neuropathy.
- Immune responses in glaucoma can be both detrimental and protective.
- Further research is crucial for understanding glaucoma neurodegeneration and developing novel therapeutic strategies, potentially identifying biomarkers for normal-tension glaucoma.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Microbiome of the Eye

